Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Atrial Natriuretic Peptide (126-149) (rat)

Name
Atrial Natriuretic Peptide (126-149) (rat)
Molecular structural formula
Purity
≥95%
CAS Number
91421-87-3
Formula
C104H168N38O33S2
MW
2542.86
Target
others
Sequence
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg(Disulfide bridge:Cys4-Cys20)
Sequence Shortening
RSSCFGGRIDRIGAQSGLGCNSFR (Disulfide bridge:Cys4-Cys20)
InChIKey
WUFHQKHAKHCKJG-NNAOVHMHSA-N
Solubility in water
50 mg/mL
References
[1]. Morozumi N, et al. ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism. PLoS One. 2019 Feb 22;14(2):e0212680. [2]. Buckley MG, et al. Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy. Clin Sci (Lond). 2000 Nov;99(5):467-72. [3]. Mazarati AM, et al. ANP(1-28), BNP(1-32) and CNP(1-22) increase the severity of picrotoxin-kindled seizure syndrome in rats. Life Sci. 1993;52(3):PL19-24.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Auriculin A is a synthetic atrial natriuretic factor (ANF) with hemodynamic effect. Auriculin A antagonizes renal vasoconstriction in the dog, and influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.